These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 21378379)

  • 1. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype.
    Bergman JE; Janssen N; Hoefsloot LH; Jongmans MC; Hofstra RM; van Ravenswaaij-Arts CM
    J Med Genet; 2011 May; 48(5):334-42. PubMed ID: 21378379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
    Marcos S; Sarfati J; Leroy C; Fouveaut C; Parent P; Metz C; Wolczynski S; Gérard M; Bieth E; Kurtz F; Verier-Mine O; Perrin L; Archambeaud F; Cabrol S; Rodien P; Hove H; Prescott T; Lacombe D; Christin-Maitre S; Touraine P; Hieronimus S; Dewailly D; Young J; Pugeat M; Hardelin JP; Dodé C
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2138-43. PubMed ID: 25077900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene.
    Jongmans MC; Admiraal RJ; van der Donk KP; Vissers LE; Baas AF; Kapusta L; van Hagen JM; Donnai D; de Ravel TJ; Veltman JA; Geurts van Kessel A; De Vries BB; Brunner HG; Hoefsloot LH; van Ravenswaaij CM
    J Med Genet; 2006 Apr; 43(4):306-14. PubMed ID: 16155193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of three novel mutations in the CHD7 gene in patients with clinical signs of typical or atypical CHARGE syndrome.
    Michelucci A; Ghirri P; Iacopetti P; Conidi ME; Fogli A; Baldinotti F; Lunardi S; Forli F; Moscuzza F; Berrettini S; Boldrini A; Simi P; Pellegrini S
    Int J Pediatr Otorhinolaryngol; 2010 Dec; 74(12):1441-4. PubMed ID: 20943277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development.
    Sanlaville D; Etchevers HC; Gonzales M; Martinovic J; Clément-Ziza M; Delezoide AL; Aubry MC; Pelet A; Chemouny S; Cruaud C; Audollent S; Esculpavit C; Goudefroye G; Ozilou C; Fredouille C; Joye N; Morichon-Delvallez N; Dumez Y; Weissenbach J; Munnich A; Amiel J; Encha-Razavi F; Lyonnet S; Vekemans M; Attié-Bitach T
    J Med Genet; 2006 Mar; 43(3):211-217. PubMed ID: 16169932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of CHARGE syndrome by identification of a novel CHD7 mutation in a previously unaffected family.
    Colin E; Bonneau D; Boussion F; Guichet A; Delorme B; Triau S; Gillard P; Kitzis A; Bilan F
    Prenat Diagn; 2012 Jul; 32(7):692-4. PubMed ID: 22517486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic spectrum of CHARGE syndrome based on clinical characteristics.
    Aksel Kılıçarslan Ö; Ataman E; Gürsoy S; Hazan F; Randa C; Çankaya T; Erçal D; Ülgenalp A; Giray Bozkaya Ö
    Turk J Med Sci; 2018 Oct; 48(5):911-915. PubMed ID: 30384553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal spectrum of CHARGE syndrome in 40 fetuses with CHD7 mutations.
    Legendre M; Gonzales M; Goudefroye G; Bilan F; Parisot P; Perez MJ; Bonnière M; Bessières B; Martinovic J; Delezoide AL; Jossic F; Fallet-Bianco C; Bucourt M; Tantau J; Loget P; Loeuillet L; Laurent N; Leroy B; Salhi H; Bigi N; Rouleau C; Guimiot F; Quélin C; Bazin A; Alby C; Ichkou A; Gesny R; Kitzis A; Ville Y; Lyonnet S; Razavi F; Gilbert-Dussardier B; Vekemans M; Attié-Bitach T
    J Med Genet; 2012 Nov; 49(11):698-707. PubMed ID: 23024289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete screening of 50 patients with CHARGE syndrome for anomalies in the CHD7 gene using a denaturing high-performance liquid chromatography-based protocol: new guidelines and a proposal for routine diagnosis.
    Bilan F; Legendre M; Charraud V; Manière B; Couet D; Gilbert-Dussardier B; Kitzis A
    J Mol Diagn; 2012 Jan; 14(1):46-55. PubMed ID: 22033296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHD7 mutations causing CHARGE syndrome are predominantly of paternal origin.
    Pauli S; von Velsen N; Burfeind P; Steckel M; Mänz J; Buchholz A; Borozdin W; Kohlhase J
    Clin Genet; 2012 Mar; 81(3):234-9. PubMed ID: 21554267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed puberty due to a novel mutation in CHD7 causing CHARGE syndrome.
    Dauber A; Hirschhorn JN; Picker J; Maher TA; Milunsky A
    Pediatrics; 2010 Dec; 126(6):e1594-8. PubMed ID: 21041284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome.
    Bergman JE; de Ronde W; Jongmans MC; Wolffenbuttel BH; Drop SL; Hermus A; Bocca G; Hoefsloot LH; van Ravenswaaij-Arts CM
    J Clin Endocrinol Metab; 2012 May; 97(5):E858-62. PubMed ID: 22399515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHD7 mutations and CHARGE syndrome in semicircular canal dysplasia.
    Green GE; Huq FS; Emery SB; Mukherji SK; Martin DM
    Otol Neurotol; 2014 Sep; 35(8):1466-70. PubMed ID: 24979395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria.
    Hale CL; Niederriter AN; Green GE; Martin DM
    Am J Med Genet A; 2016 Feb; 170A(2):344-354. PubMed ID: 26590800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype in 18 Danish subjects with genetically verified CHARGE syndrome.
    Husu E; Hove HD; Farholt S; Bille M; Tranebjærg L; Vogel I; Kreiborg S
    Clin Genet; 2013 Feb; 83(2):125-34. PubMed ID: 22462537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome.
    Bergman JE; Janssen N; van der Sloot AM; de Walle HE; Schoots J; Rendtorff ND; Tranebjaerg L; Hoefsloot LH; van Ravenswaaij-Arts CM; Hofstra RM
    Hum Mutat; 2012 Aug; 33(8):1251-60. PubMed ID: 22539353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel CHD7 mutations contributing to the mutation spectrum in patients with CHARGE syndrome.
    Wessels K; Bohnhorst B; Luhmer I; Morlot S; Bohring A; Jonasson J; Epplen JT; Gadzicki D; Glaser S; Göhring G; Mälzer M; Hein A; Arslan-Kirchner M; Stuhrmann M; Schmidtke J; Pabst B
    Eur J Med Genet; 2010; 53(5):280-5. PubMed ID: 20624498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiac phenotype in patients with a CHD7 mutation.
    Corsten-Janssen N; Kerstjens-Frederikse WS; du Marchie Sarvaas GJ; Baardman ME; Bakker MK; Bergman JE; Hove HD; Heimdal KR; Rustad CF; Hennekam RC; Hofstra RM; Hoefsloot LH; Van Ravenswaaij-Arts CM; Kapusta L
    Circ Cardiovasc Genet; 2013 Jun; 6(3):248-54. PubMed ID: 23677905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation update on the CHD7 gene involved in CHARGE syndrome.
    Janssen N; Bergman JE; Swertz MA; Tranebjaerg L; Lodahl M; Schoots J; Hofstra RM; van Ravenswaaij-Arts CM; Hoefsloot LH
    Hum Mutat; 2012 Aug; 33(8):1149-60. PubMed ID: 22461308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined microdeletions and CHD7 mutation causing severe CHARGE/DiGeorge syndrome: clinical presentation and molecular investigation by array-CGH.
    Kaliakatsos M; Giannakopoulos A; Fryssira H; Kanariou M; Skiathitou AV; Siahanidou T; Giannikou K; Makrythanasis P; Kanavakis E; Tzetis M
    J Hum Genet; 2010 Nov; 55(11):761-3. PubMed ID: 20686492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.